Skip to main content
. 2008 May;86(5):381–389. doi: 10.2471/BLT.07.048462

Table 2. Description of programmes among 27 countries reporting implementation of CCM of pneumonia, by geographic region.

Characteristic No. of reportsa
Asiab Africac Total
Lead agency of CCM programmed
Ministry of Health 11/12 (92) 10/15 (67) 21/27 (78)
Research institution 0/12 (0) 3/15 (20) 3/27 (11)
NGOs 3/12 (25) 4/15 (27) 7/27 (26)
CHW characterizationd
Community worker 3/12 (25) 13/15 (87) 16/27 (59)
Government worker 8/12 (67) 4/15 (27) 12/27 (44)
NGO/project worker 6/12 (50) 3/15 (20) 9/27 (33)
Financial payment for CHW 6/12 (50) 3/15 (21) 9/27 (33)
Client pays for treatment 4/12 (33) 8/14 (57) 12/26 (46)
If pays, some exemptions 3/4 (75) 3/8 (38) 6/12 (50)
Quality monitoring 10/11 (91) 14/14 (100) 24/25 (92)
Scope of programmed
ORS 12/12 (100) 15/15 (100) 27/27 (100)
Zinc for diarrhoea 3/12 (25) 7/15 (47) 10/27 (37)
Antimalarials (non-ACT) 6/12 (50) 12/15 (80) 18/27 (67)
Antimalarials (ACT) 4/12 (33) 9/15 (60) 13/27 (48)
Type of supporting policy
Official written policy 2/10 (20) 2/14 (14) 4/24 (17)
Official recommendation 7/10 (70) 6/14 (43) 13/24 (54)
Locally recommended 0/10 (0) 3/14 (21) 3/24 (13)
No policy, but allowed in pilot 1/10 (10) 3/14 (21) 4/24 (17)

ACT, artemisinin combination therapies; CCM, community case management; CHW, community health worker; NGO, nongovernmental organization; ORS, oral rehydration solution.
a Values in parentheses are percentages.
b Afghanistan, Bangladesh, Cambodia, China, India, Indonesia, Myanmar, Nepal, Pakistan, Tajikistan, Turkmenistan and Yemen.
c Benin, Democratic Republic of Congo, Ethiopia, Gambia, Ghana, Madagascar, Malawi, Mali, Niger, Senegal, Sierra Leone, Sudan, Togo, Uganda and Zambia.
d Multiple responses possible.